Skip to main content

Want a detailed portfolio tracker?

NovaBridge Biosciences. (NBP) P/E (2020 - 2026)

NovaBridge Biosciences. (NBP) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM NovaBridge Biosciences. (NBP) P/E is -11.69. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of NovaBridge Biosciences. (NBP)

YearP/EChange
2026-11.69-54.02%
2025-25.43+12.87%
2024-22.53+5092.92%
2023-0.43-52.35%
2022-0.91-91.18%
2021-10.32-122.03%
202046.86N/A

Comparison NovaBridge Biosciences. (NBP) P/E with competitors

NovaBridge Biosciences. (NBP) P/E is -11.69.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.64%
FGENFibroGen Inc0.24-102.05%
CHRSCoherus Biosciences Inc0.85-107.26%
FBIOFortress Biotech Inc0.95-108.12%
ORMPOramed Pharmaceuticals Inc1.50-112.85%
AGENAgenus Inc3.01-125.74%
INVAInnoviva Inc3.15-126.97%
VXRTVaxart Inc3.55-130.36%
CRMDCorMedix Inc3.63-131.03%
CVACCureVac N.V.4.45-138.02%
GLPGGalapagos NV4.86-141.55%
SRPTSarepta Therapeutics Inc4.88-141.75%
ABEOAbeona Therapeutics Inc5.39-146.07%
ABUSArbutus Biopharma Corp5.60-147.85%
ZVRAZevra Therapeutics Inc5.89-150.35%
SPROSpero Therapeutics Inc6.23-153.26%
CGENCompugen Ltd6.31-153.99%
RIGLRigel Pharmaceuticals6.87-158.77%
SLXNSilexion Therapeutics Corp7.30-162.39%
OMEROmeros Corporation9.26-179.18%
AUPHAurinia Pharmaceuticals Inc9.58-181.97%
PLXProtalix BioTherapeutics Inc10.89-193.14%
ACADAcadia Pharmaceuticals Inc11.73-200.30%
TBPHTheravance Biopharma Inc12.26-204.86%
ADMAAdma Biologics Inc12.42-206.20%
HRMYHarmony Biosciences Holdings Inc13.82-218.19%
SABSSAB Biotherapeutics Inc14.14-220.89%
NAGENiagen Bioscience Inc14.82-226.72%
INCYIncyte Corp15.82-235.31%
REGNRegeneron Pharmaceuticals Inc15.86-235.60%
PBYIPuma Biotechnology Inc17.32-248.08%
CPRXCatalyst Pharmaceuticals Inc17.44-249.14%
EXELExelixis Inc17.54-249.98%
TGTXTG Therapeutics Inc18.97-262.19%
MDXGMimedx Group Inc20.55-275.76%
XOMAXOMA Royalty Corp22.87-295.62%
ARGXArgen X SE24.30-307.80%
CTMXCytomX Therapeutics Inc24.82-312.27%
XOMAOXOMA Royalty Corp25.34-316.75%
HALOHalozyme Therapeutics Inc25.62-319.13%
XOMAPXOMA Royalty Corp25.67-319.53%
VRTXVertex Pharmaceuticals Inc27.99-339.41%
RPRXRoyalty Pharma plc - Class A28.69-345.33%
SLNOSoleno Therapeutics Inc29.02-348.14%
ASNDAscendis Pharma A/S30.09-357.29%
LGNDLigand Pharmaceuticals Inc - Class B37.91-424.22%
APLSApellis Pharmaceuticals Inc39.02-433.71%
BMRNBiomarin Pharmaceutical Inc42.21-460.99%
KRYSKrystal Biotech Inc45.34-487.78%
ONCBeiGene Ltd69.54-694.71%
PHARPharming Group N.V.75.03-741.62%
TECHBio-Techne Corp101.96-971.94%
VCELVericel Corp109.92-1040.04%
ALNYAlnylam Pharmaceuticals Inc117.96-1108.83%
GMABGenmab140.29-1299.76%
TLXTelix Pharmaceuticals Ltd162.15-1486.73%
CORTCorcept Therapeutics Inc212.86-1920.35%